Cocrystal Pharma Inc. (COCP) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cocrystal Pharma Inc.

    NASDAQ: COCP · Real-Time Price · USD
    1.50
    0.02 (1.69%)
    At close: Sep 08, 2025, 3:59 PM
    1.48
    -1.33%
    After-hours: Sep 08, 2025, 04:43 PM EDT

    Cocrystal Pharma Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -17.5M -17.98M -38.84M -14.19M
    Depreciation & Amortization
    		 126K -1.39M 388K 190K
    Stock-Based Compensation
    		 643K 801K 855K 724K
    Other Working Capital
    		 1.36M 296K -2.39M 240K
    Other Non-Cash Items
    		 110K 1.56M 18.87M -195K
    Deferred Income Tax
    		 n/a n/a n/a -49K
    Change in Working Capital
    		 140K 2.34M -2.71M 796K
    Operating Cash Flow
    		 -16.48M -14.67M -21.43M -12.72M
    Capital Expenditures
    		 -8K -118K -74K -52K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 -8K -118K -74K -52K
    Debt Repayment
    		 n/a -7K -27K -39K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a n/a n/a n/a
    Financial Cash Flow
    		 n/a 3.99M -27K 38.47M
    Net Cash Flow
    		 -16.49M -10.79M -21.54M 25.7M
    Free Cash Flow
    		 -16.49M -14.78M -21.51M -12.77M

    Add to Watchlist